Round-up of news & views from AAPS & CPhI 2011

By Nick Taylor

- Last updated on GMT

Outsourcing-Pharma presents a roundup of news and views shared by exhibitors and attendees at AAPS and CPhI.

Last week Outsourcing-Pharma joined the biopharm industry in Washington, DC for AAPS and Frankfurt, Germany for CPhI to discuss issues affecting drug development and manufacture.

Attendees of both trade shows took to social media to share their thoughts on topics such as globalisation and regulation. Outsourcing-Pharma has selected the best of the posts to give you an insight into the topics being discussed at both conferences.

To share your views on AAPS or CPhI get in touch with us via the comment section below or by contacting @OutsourcPharma​ on Twitter. Also, thank you to everyone who has made this curation possible by sharing news and developments from AAPS and CPhI.

Related news

Related products

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...


Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...


Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers